Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Genomics

Professor discovers gene that predicts time of deathThe Toronto Star Share It appears the Grim Reaper has a schedule to keep. A team of scientists led by a University of Toronto neurology professor says it has discovered a gene mutation that determines the time of day a person is most likely to die.More

New genetic test provides precise, yet hazy resultsThe Journal News via USA Today Share A new test, chromosomal microarray technology, is providing doctors and prospective parents with more information than ever before about the genetic makeup of a baby still in the womb. But what that knowledge actually means is not always clear, causing confusion and anxiety for parents and physicians.More

Earn your MS in Nursing OnlineNursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

Discover the Concentra Difference. Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.

Regenerative Medicine

Study: A person's DNA isn't always identicalVoice of America Share Prevailing wisdom holds that every cell in the body contains identical DNA. But Yale researchers say they examined skin stem cells and found a number of genetic variations in a variety of skin tissue.More

Stem cell clinical trials to tackle diabetesHealthCanal Share NUI Galway has been awarded a major new project designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.More

Expert: Medical device tax could crimp long-term care suppliesMcKnight's Long-Term Care News Assisted Living Share A medical device excise tax scheduled to hit Jan. 1, is causing uncertainty among manufacturers and providers, a healthcare expert said. The 2.3 percent tax will be on sales of FDA-approved devices that are used by a physician or in a physician's office. It's intended to generate $20 billion over the next several years, which is expected to offset some healthcare reform costs. More

Managed Healthcare News

Growing hospice costs focus of Medicare auditsSan Diego Union-Tribune Share Once the domain of volunteers and churches, hospice is now a multibillion-dollar nationwide industry, with growth rates over the last decade that would please even the most ambitious financial manager. Medicare payments to hospice programs have ballooned from $3 billion in 2000 to $13 billion in 2010, turning what was formerly a minor expense into a target of government auditors desperate to rein in soaring medical costs.More

Study: Uninsured die at higher rates after brain surgeryKaiser Health News Share Your chances of surviving brain surgery might be affected by whether you have health insurance. According to the findings of a new study, uninsured patients died at a higher rate after receiving brain surgery to remove cancerous tumors than those with private insurance. Uninsured patients had a death rate of 2.6 percent, compared to 1.3 percent among the privately insured, a statistically significant difference.More

Medicare cuts give health providers jittersPolitico Share The $716 billion in Medicare "cuts" that got so much attention in the presidential election have already begun sinking their teeth into healthcare providers. And there are widespread jitters that any further cuts as part of a year-end deal to stave off sequestration or strike a "grand bargain" for a long-term fiscal deal would deeply gouge some providers, if not put them out of business.More

FDA: New Treatments and Technology

Testosterone, Viagra not a winning ED combinationReuters Share Using a testosterone gel in addition to Viagra doesn't make the little blue pill work any better, according to a new study. The report's lead researcher said testosterone is typically prescribed to men who have both low testosterone levels and symptoms such as little interest in sex or low bone and muscle mass.More

FDA panel backs hepatitis B vaccine efficacy, not safetyReuters Share A Food and Drug Administration panel voted unanimously to recommend the effectiveness of Dynavax Inc.'s hepatitis B vaccine Heplisav, but raised concerns about its safety, asking for more data from studies on a wider population.More

FAST FACTS"Diabetes causes more deaths a year than breast cancer and AIDS combined, according to the American Diabetes Association."

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!